No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
BNGO240517P1000
- 0.15
- +0.05+50.00%
15min DelayClose May 8 16:00 ET
0.15High0.05Low
0.15Open0.10Pre Close11 Volume1.60K Open Interest1.00Strike Price155.00Turnover177.97%IV-7.61%PremiumMay 17, 2024Expiry Date0.08Intrinsic Value100Multiplier8DDays to Expiry0.07Time Value100Contract SizeAmericanOptions Type-0.5625Delta1.5428Gamma6.13Leverage Ratio-0.0057Theta-0.0001Rho-3.45Eff Leverage0.0006Vega
Intraday
- 5D
- 1D
News
Bionano Genomics Inc (BNGO) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth ...
Bionano Genomics, Inc. (BNGO) Q1 2024 Earnings Call Transcript
Bionano Genomics, Inc. (BNGO) Q1 2024 Earnings Call Transcript
Bionano Genomics (BNGO) Q1 2024 Earnings Call Transcript
Bionano Reaffirms FY24 Revenue Guidance $37M-$41M
Bionano Reaffirms FY24 Revenue Guidance $37M-$41M
Bionano Genomics up 7% on Narrowed Quarterly Loss, Revenue Beat
Bionano Genomics Q1 2024 GAAP EPS $(0.60) Beats $(0.65) Estimate, Sales $8.769M Beat $8.492M Estimate
Bionano Genomics (NASDAQ:BNGO) reported quarterly losses of $(0.60) per share which beat the analyst consensus estimate of $(0.65) by 7.69 percent. This is a 51.22 percent increase over losses of $(1.
Comments
$Bionano Genomics(BNGO.US$ Bionano Genomics Q1 2024 GAAP EPS $(0.60) Beats $(0.65) Estimate, Sales $8.769M Beat $8.492M Estimate
Benzinga· 1 min ago
Bionano Genomics (NASDAQ:BNGO) reported quarterly losses of $(0.60) per share which beat the analyst consensus estimate of $(0.65) by 7.69 percent. This is a 51.22 percent increase over losses of $(1.23) per share from the same period last year. The company reported quarterly sales of $8.769 million which beat the analyst consensus estimate of ...
Benzinga· 1 min ago
Bionano Genomics (NASDAQ:BNGO) reported quarterly losses of $(0.60) per share which beat the analyst consensus estimate of $(0.65) by 7.69 percent. This is a 51.22 percent increase over losses of $(1.23) per share from the same period last year. The company reported quarterly sales of $8.769 million which beat the analyst consensus estimate of ...
$Bionano Genomics(BNGO.US$ $0.08 per shares now 🤣🤣🤣🤣 used to he $12 at lrak LMFAO
$Bionano Genomics(BNGO.US$ Bionano and Diagens Sign Partnership to Commercialize the First Ever Clinical Cytogenetic Analysis That Combines Ogm and Artificial Intelligence
$Bionano Genomics(BNGO.US$ b i n go b i ngo b i ngo and bingo crashed to 1 cent !
$Bionano Genomics(BNGO.US$ Bionano Announces Publication Showing That OGM Detects Over 1250 Structural Variants, Including 56 Gene Fusions, In Pediatric Leukemia That Were Missed By Whole Genome Sequencing
Benzinga· just
Bionano Genomics, Inc. (NASDAQ:BNGO) today announced the publication of a study from Penn State College of Medicine that used optical genome mapping (OGM) to search for clinically and biologically relevant genomic variations in pediatric B-cell acute lymphoblastic leukemi...
Benzinga· just
Bionano Genomics, Inc. (NASDAQ:BNGO) today announced the publication of a study from Penn State College of Medicine that used optical genome mapping (OGM) to search for clinically and biologically relevant genomic variations in pediatric B-cell acute lymphoblastic leukemi...
Read more